TRANSITION AND SEPARATION AGREEMENTTransition and Separation Agreement • November 4th, 2015 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations • California
This Transition and Separation Agreement (the “Agreement”) by and between Howard Raff (“Executive”) and Aimmune Therapeutics, Inc., a Delaware corporation (the “Company”), is made effective as of the eighth (8th) day following the date Executive signs this Agreement (the “Effective Date”) with reference to the following facts:
